Literature DB >> 29605075

Liver Transplantation for Acute Liver Failure.

Raquel Olivo1, James V Guarrera2, Nikolaos T Pyrsopoulos3.   

Abstract

With the advent of liver transplant for acute liver failure (ALF), survival rate has improved drastically. Liver transplant for ALF accounts for 8% of all transplant cases. The 1-year survival rates are 79% in Europe and 84% in the United States. Some patients with ALF may recover spontaneously, and approximately half will undergo liver transplant. It is imperative to identify patients with ALF as soon as possible to transfer them to a liver transplant center for a thorough evaluation. Emergent liver transplant in a patient with ALF may place the patient at risk for severe complications in the postoperative period.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute liver failure; Liver transplant; Living donor liver transplant

Mesh:

Year:  2018        PMID: 29605075     DOI: 10.1016/j.cld.2018.01.014

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  13 in total

1.  Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell.

Authors:  Haiyan Wang; Xuehui Li; Guanjun Dong; Fenglian Yan; Junfeng Zhang; Hui Shi; Zhaochen Ning; Min Gao; Dalei Cheng; Qun Ma; Changying Wang; Mingsheng Zhao; Jun Dai; Chunxia Li; Zhihua Li; Hui Zhang; Huabao Xiong
Journal:  Inflammation       Date:  2020-10-20       Impact factor: 4.092

Review 2.  Liver Transplantation for Acute Liver Failure in Presence of Acute Kidney Injury.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2019-07-25

3.  Identifying the Mechanism of Polygoni Cuspidati Rhizoma et Radix in Treating Acute Liver Failure Based on Network Pharmacology and Molecular Docking.

Authors:  Jing Hong; Jie Ding; Han-Han Hong; Xiao-Wan Xu; Bo Pan; Yi Ruan; Xiao-Feng Zhai
Journal:  Gastroenterol Res Pract       Date:  2022-04-08       Impact factor: 1.919

4.  Sinapic acid ameliorates paracetamol-induced acute liver injury through targeting oxidative stress and inflammation.

Authors:  Amir Rostami; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Mol Biol Rep       Date:  2022-03-13       Impact factor: 2.742

5.  Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site.

Authors:  Yao Wang; Qian Chen; Fangzhou Jiao; Chunxia Shi; Maohua Pei; Luwen Wang; Zuojiong Gong
Journal:  Cell Death Dis       Date:  2021-01-11       Impact factor: 8.469

Review 6.  Liver failure-future challenges and remaining questions.

Authors:  Peter Lemmer; Josef Christian Pospiech; Ali Canbay
Journal:  Ann Transl Med       Date:  2021-04

7.  Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study.

Authors:  Christina Scharf; Uwe Liebchen; Michael Paal; Andrea Becker-Pennrich; Michael Irlbeck; Michael Zoller; Ines Schroeder
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Impact of Perioperative Massive Transfusion on Long Term Outcomes of Liver Transplantation: a Retrospective Cohort Study.

Authors:  Lingcan Tan; Xiaozhen Wei; Jianming Yue; Yaoxin Yang; Weiyi Zhang; Tao Zhu
Journal:  Int J Med Sci       Date:  2021-10-15       Impact factor: 3.738

9.  Extracellular Vesicles Secreted by Human Adipose-derived Stem Cells (hASCs) Improve Survival Rate of Rats with Acute Liver Failure by Releasing lncRNA H19.

Authors:  Yinpeng Jin; Junyi Wang; Hongchao Li; Shane Gao; Rongfeng Shi; Danjing Yang; Xianli Wang; Xi Wang; Liang Zhu; Xiaojin Wang; Chengwei Chen; Ke Ning; Zhengliang Gao; Jun Xu; Qingchun Fu
Journal:  EBioMedicine       Date:  2018-08-02       Impact factor: 8.143

10.  Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy.

Authors:  Zihao Fan; Yuxian Li; Sisi Chen; Ling Xu; Yuan Tian; Yaling Cao; Zhenzhen Pan; Xiangying Zhang; Yu Chen; Feng Ren
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.